{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:06:33Z","timestamp":1791407193493,"version":"4.3.3"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T00:00:00Z","timestamp":1607817600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiac troponin I (cTnI) and cTnT are the established biomarkers of cardiomyocyte damage and the recommended biomarkers for the diagnosis of acute myocardial infarction (MI). High-sensitivity immunochemical diagnostic systems are able to measure the cTn concentrations in the blood of a majority of healthy people. At the same time, the concentration of cTn may be increased not only after MI but also because of other pathologies that might affect myocardium. This effect reduces the clinical specificity of cTn for MI and may complicate the diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>This review summarizes the existing information regarding the causes and mechanisms that lead to the increase of cTn concentration in blood and the forms of cTn that are present in circulation after MI or other types of myocardial injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Different etiologies of disease associated with increases of cTn above the 99th percentile and various mechanisms of troponin release from myocardium could result in the appearance of different forms of cTn in blood and provide the first clinical evidence of injury. Additional research is needed for the careful characterization of cTn forms that are present in the blood in different clinical settings. That knowledge may lead to the development of immunochemical systems that would differentiate certain forms of troponins and possibly certain types of cardiac disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaa281","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T07:09:47Z","timestamp":1605078587000},"page":"124-130","source":"Crossref","is-referenced-by-count":118,"title":["Myocardial Injury and the Release of Troponins I and T in the Blood of Patients"],"prefix":"10.1093","volume":"67","author":[{"given":"Ivan A","family":"Katrukha","sequence":"first","affiliation":[{"name":"HyTest Ltd., Turku, Finland"},{"name":"Department of Biochemistry, School of Biology, MV Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey G","family":"Katrukha","sequence":"additional","affiliation":[{"name":"HyTest Ltd., Turku, Finland"},{"name":"Department of Biochemistry, School of Biology, MV Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,12]]},"reference":[{"key":"2021010814310308200_hvaa281-B1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-4-431-38453-3_4","article-title":"Troponin: structure, function and dysfunction","volume":"592","author":"Ohtsuki","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"2021010814310308200_hvaa281-B2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1134\/S0006297913130063","article-title":"Human cardiac troponin complex. Structure and functions","volume":"78","author":"Katrukha","year":"2013","journal-title":"Biochem Moscow"},{"key":"2021010814310308200_hvaa281-B3","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"2021010814310308200_hvaa281-B4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1373\/clinchem.2012.192716","article-title":"Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population","volume":"58","author":"Apple","year":"2012","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B5","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1515\/cclm-2016-0933","article-title":"The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications","volume":"55","author":"Clerico","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2021010814310308200_hvaa281-B6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00424-007-0354-8","article-title":"Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation","volume":"455","author":"Hessel","year":"2008","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"2021010814310308200_hvaa281-B7","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1515\/CCLM.2009.320","article-title":"Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?","volume":"47","author":"Giannoni","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"2021010814310308200_hvaa281-B8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0009-9120(96)00105-1","article-title":"Release kinetics of serum cardiac troponin I in ischemic myocardial injury","volume":"29","author":"Bertinchant","year":"1996","journal-title":"Clin Biochem"},{"key":"2021010814310308200_hvaa281-B9","first-page":"354","article-title":"Kinetics of high-sensitivity cardiac troponin T and I differ in patients with st-segment elevation myocardial infarction treated by primary coronary intervention","volume":"5","author":"Laugaudin","year":"2016","journal-title":"Eur Heart J: Acute Cardiovas Care"},{"key":"2021010814310308200_hvaa281-B10","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","article-title":"Direct comparison of high-sensitivity-cardiac troponin I vs T for the early diagnosis of acute myocardial infarction","volume":"35","author":"Rubini Gimenez","year":"2014","journal-title":"Eur Heart J"},{"key":"2021010814310308200_hvaa281-B11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1373\/clinchem.2018.301127","article-title":"Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction","volume":"65","author":"Vylegzhanina","year":"2019","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1517\/17425255.1.4.715","article-title":"Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection","volume":"1","author":"Gaze","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2021010814310308200_hvaa281-B13","first-page":"1","article-title":"Elevated cardiac troponins in setting of systemic inflammatory response syndrome, sepsis, and septic shock","volume":"2013","author":"Hussain","year":"2013","journal-title":"ISRN Cardiol"},{"key":"2021010814310308200_hvaa281-B14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/jcm9051407","article-title":"Impact of COVID-19 on the cardiovascular system: a review","volume":"9","author":"Matsushita","year":"2020","journal-title":"J Clin Med"},{"key":"2021010814310308200_hvaa281-B15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajem.2018.10.002","article-title":"Serum cardiac troponins as prognostic markers in patients with traumatic and non-traumatic brain injuries: a meta-analysis","volume":"37","author":"El-Menyar","year":"2019","journal-title":"Am J Emerg Med"},{"key":"2021010814310308200_hvaa281-B16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2019.04.005","article-title":"A troponin study on patients with ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage: type II myocardial infarction is significantly associated with stroke severity, discharge disposition and mortality","volume":"64","author":"Alkhachroum","year":"2019","journal-title":"J Clin Neurosci"},{"key":"2021010814310308200_hvaa281-B17","first-page":"181","article-title":"Exercise-induced cardiac troponin elevation: an update on the evidence, mechanism and implications","volume":"22","author":"Baker","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2021010814310308200_hvaa281-B18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/toxsci\/kfr190","article-title":"The complete pharmacokinetic profile of serum cardiac troponin I in the rat and the dog","volume":"123","author":"Dunn","year":"2011","journal-title":"Toxicol Sci"},{"key":"2021010814310308200_hvaa281-B19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/clinchem\/hvz003","article-title":"A possible mechanism behind faster clearance and higher peak concentrations of cardiac troponin I compared with troponin T in acute myocardial infarction","volume":"66","author":"Starnberg","year":"2020","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCGENETICS.115.001322","article-title":"Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease","volume":"9","author":"Wens","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"2021010814310308200_hvaa281-B21","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2021010814310308200_hvaa281-B22","first-page":"189","article-title":"Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations","volume":"6","author":"Giannitsis","year":"2019","journal-title":"Diagnosis (Berlin, Germany"},{"key":"2021010814310308200_hvaa281-B23","first-page":"1852","article-title":"Lentivirus mediated interference of caspase-3 expression ameliorates the heart function on rats with acute myocardial infarction","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2021010814310308200_hvaa281-B24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacbts.2017.01.006","article-title":"Brief myocardial ischemia produces cardiac troponin I release and focal myocyte apoptosis in the absence of pathological infarction in swine","volume":"2","author":"Weil","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"2021010814310308200_hvaa281-B25","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1016\/j.jacc.2018.04.029","article-title":"Troponin release and reversible left ventricular dysfunction after transient pressure overload","volume":"71","author":"Weil","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2021010814310308200_hvaa281-B26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2009.12.009","article-title":"Cardiac troponin may be released by ischemia alone, without necrosis","volume":"411","author":"Hickman","year":"2010","journal-title":"Clin Chim Acta"},{"key":"2021010814310308200_hvaa281-B27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/1354750X.2018.1490969","article-title":"Possible mechanisms behind cardiac troponin elevations","volume":"23","author":"Hammarsten","year":"2018","journal-title":"Biomarkers"},{"key":"2021010814310308200_hvaa281-B28","doi-asserted-by":"crossref","first-page":"11681","DOI":"10.1021\/bi060273s","article-title":"Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage","volume":"45","author":"Zhang","year":"2006","journal-title":"Biochemistry"},{"key":"2021010814310308200_hvaa281-B29","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/clinchem\/44.12.2433","article-title":"Degradation of cardiac troponin I: implication for reliable immunodetection","volume":"44","author":"Katrukha","year":"1998","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000028818.33488.7B","article-title":"Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury","volume":"106","author":"Wang","year":"2002","journal-title":"Circulation"},{"key":"2021010814310308200_hvaa281-B31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.res.0000435855.49359.47","article-title":"Role of troponin I proteolysis in the pathogenesis of stunned myocardium","volume":"80","author":"Gao","year":"1997","journal-title":"Circ Res"},{"key":"2021010814310308200_hvaa281-B32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbagen.2019.01.008","article-title":"Structure and proteolytic susceptibility of the inhibitory c-terminal tail of cardiac troponin I","volume":"1863","author":"Mahmud","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2021010814310308200_hvaa281-B33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1373\/clinchem.2017.286211","article-title":"Full-size cardiac troponin I and its proteolytic fragments in blood of patients with acute myocardial infarction: antibody selection for assay development","volume":"64","author":"Katrukha","year":"2018","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1373\/clinchem.2016.261511","article-title":"Identification and characterization of cardiac troponin T fragments in serum of patients suffering from acute myocardial infarction","volume":"63","author":"Streng","year":"2017","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B35","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1373\/clinchem.2016.266635","article-title":"Thrombin-mediated degradation of human cardiac troponin T","volume":"63","author":"Katrukha","year":"2017","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/clinchem\/44.6.1198","article-title":"Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization","volume":"44","author":"Wu","year":"1998","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B37","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1373\/clinchem.2009.133546","article-title":"Circulating immunoreactive cardiac troponin forms determined by gel filtration chromatography after acute myocardial infarction","volume":"56","author":"Bates","year":"2010","journal-title":"Clin Chem"},{"key":"2021010814310308200_hvaa281-B38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clinbiochem.2019.06.012","article-title":"Cardiac troponin I is present in plasma of type 1 myocardial infarction patients and patients with troponin I elevations due to other etiologies as complex with little free I","volume":"73","author":"van Wijk","year":"2019","journal-title":"Clin Biochem"},{"key":"2021010814310308200_hvaa281-B39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1373\/jalm.2018.027144","article-title":"Cardiac troponin T: only small molecules in recreational runners after marathon completion","volume":"3","author":"Vroemen","year":"2019","journal-title":"J Appl Lab Med"},{"key":"2021010814310308200_hvaa281-B40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1373\/clinchem.2016.261644","article-title":"Cardiac troponin T: smaller molecules in patients with end-stage renal disease than after onset of acute myocardial infarction","volume":"63","author":"Mingels","year":"2017","journal-title":"Clin Chem"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/1\/124\/35548486\/hvaa281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/67\/1\/124\/35548486\/hvaa281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:16:45Z","timestamp":1610565405000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/67\/1\/124\/6032254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12,12]]},"published-print":{"date-parts":[[2021,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaa281","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,12,12]]}}}